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ROLE OF MAGNETIC RESONANCE IMAGING FUSION PROSTATE BIOPSY IN PATIENTS WITH PROSTATE 
CANCER ON ACTIVE SURVEILLANCE WHO WENT ON TO HAVE A RADICAL PROSTATECTOMY. 
 
Isaac Palma-Zamora, Akshay Sood, Philip Olson, Guillaume Farah, Deepansh Dalela, Sohrab Arora, 
Marcus Jamil, Jacob Keeley, Natalija Kovacevic, James Peabody, Craig Rogers, Mani Menon, Ali 
Dabaja, Firas Abdollah  
Department of Urology, Henry Ford Health System, Detroit, MI 
 
INTRODUCTION:  
Patients with low-risk clinically localized prostate cancer may forgo immediate treatment and opt for 
active surveillance (AS). Follow up biopsies are an essential component of AS protocols. Our study 
evaluates the use of MRI Fusion prostate biopsy (MFB) in patients on active surveillance who went on to 
have definitive surgical management.  
 
METHODS: 
Single institution retrospective review of 221 patients who underwent MFB between October 2015 and 
August 2019. Gleason scores from double sextant 12-core specimens were compared to those of regions 
of interest, and to the final pathology specimen where appropriate. Upgrading was defined as Gleason 
score 6 on biopsy, showing a pathological score of 3+4 or above, while downgrading was the reverse.  
 
RESULTS: 
In patients on active surveillance, the rate of cancer detection on subsequent biopsies is similar between 
TRUS and MFB (77% vs 77%, p=0.87). Of the 29 patients that had radical prostatectomy 26 out of 29 had 
positive TRUS cores compared to 27 out of 29 that had positive MFB cores. The final pathological score 
coincided with TRUS and MFB on 30% and 44% of the time (p=0.30), respectively. Similar upgrading rates 
were noted between TRUS and MFB (44% and 53%, p=0.61).  
 
CONCLUSIONS: 
Detection cancer rates and concordance with final pathology appear to be similar between the TRUS and 
MFB approaches. Given the similarity in detection rate and concordance of Gleason score with final 
pathology, the utilization of MFB might not be warented for patients on AS, as it is associated with higher 
financial burden. 
 
  
